Posts

Showing posts from July, 2024
Image
  Sanwire Corporation engages PCAOB-registered auditor and accounting firm to prepare for SEC Form 10 filing New York, July 15, 2024 - PRISM MediaWire - Sanwire Corporation (OTC: SNWR), a multifaceted company focused on integrating cutting-edge technologies across various industries, is thrilled to announce its partnership with Fruci & Associates II, PLLC , a reputable accounting and auditing firm registered with the Public Company Accounting Oversight Board (PCAOB). This collaboration entails a comprehensive two-year examination of the company's financial records, a crucial step toward ensuring accuracy and transparency in financial reporting. Once the audit is successfully completed, Sanwire Corporation is poised to file Form 10 with the Securities and Exchange Commission (SEC), a milestone that will grant the company full reporting status. Ron Hughes, the esteemed President and CEO of Sanwire, has expressed his eager anticipation for the audit's conclusion, recognizi
Image
 SKYX Announces Production of its New Global Patented Advanced, Smart, Plug & Play Recessed Light The Global Recessed Light Market is a Multi-Billion Unit Market As SKYX Continues to Grow its Market Penetration it Expects its Recessed Light to Significantly Contribute to Growth          SKYX’s New Plug & Play Recessed Light Global Patents include the U.S., China, Canada, Hong-Kong and Mexico Miami, FL, July 11, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home d├ęcor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard announced today that it will start production of its new global patented advanced, smart, plug & play recessed light . The global recessed light market is a multi-billion-unit market. SKYX’s new Plug & Play recessed light g
Image
 MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode HOLLAND, Mich., July 11, 2024 – MedTech Gurus, a leading podcast focused on the forefront of medical technology, featured Oncocyte Corporation (NASDAQ: OCX) CEO Josh Riggs in its latest episode, "Take Advantage of the Moment." In this episode, Riggs highlights Oncocyte's innovative strategies in molecular diagnostic technology and the significant impact of this technology on patient care. Hosted by Tom Hickey, a partner at Excelerant Consulting and a seasoned expert in medical device commercialization, the episode delves into Riggs’ journey at Oncocyte, from his start as Senior Director of Business Development and General Manager of the Transplant Division to his leadership as CEO. The discussion also explores his entrepreneurial ventures prior to Oncocyte, including co-founding Explorgen, a consumer genomics company, and Vinome, which personalized wine
Image
  SMC Announces Retirement of Additional $436,884 of Debt Boca Raton, FL, July 11, 2024 - SMC Entertainment, Inc. ("SMC" or the "Company") (OTC: SMCE), a versatile incubator company focused on acquisition and support of proven commercialized financial services and technology (Fintech) companies, is pleased to announce the retirement of an additional $436,884 of debt in the form of consulting fees and management conversion of accrued earnings (the “Debt”). The Debt retirement will be reflected in the Company's third quarter 2024 financial statements. The Debt is comprised of $300,374 held by one of our non-affiliate debt holders. The balance of $136,500 is comprised of accrued consulting fees held by current insiders, and all of the Debt was converted to the Company’s common shares at $0.002 per share, for a total of 68,250,000. All share issuances are restricted in accordance with the Securities and Exchange Commission (“SEC”) Rule 144. “We believe that
Image
  Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns LAS VEGAS, NEVADA, July 10, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a leader in artificial intelligence (AI) technology specializing in cutting edge AI and data center infrastructure solutions, today announced its planned state-of-the-art data centers, outfitted with immersible AI supercomputer servers, will address a number of unmet needs in the AI and big data industry’s rapid growth, while answering key sustainability and infrastructure concerns arising in the communities that support data centers.  For the needs of AI and big data companies, Avant expects to deliver more data capabilities, specialized attention to each client, and a most cost-effective option. Meanwhile, Avant plans to introduce data centers with a smaller footprint and that draw less energy from the local community, which will quell sustainability concerns. Avant’s Chief Executive
Image
  BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers POMPANO BEACH, FL, July 10, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a clinical study to evaluate AmnioWrap2™ (AW2) in diabetic foot ulcers (DFU), one of the company’s placental-derived allograft commercial products. Jason Matuszewski, CEO of BioStem, commented: “Diabetic foot ulcers are a critical health issue and can lead to lower limb amputations, illness and death in diabetic patients. The medical community is constantly seeking new treatments to prevent or lessen these complications and their considerable impact on patients, families, and the healthcare system as a whole. Our clinical team has developed a novel, standardized clinical trial protoc
Image
  Neon Bloom Changes Course With New Leadership and Divestment of Bazelet™ Recent Acquisition Leads to New Management and Expanding Focus On Financial Services Sector NEWPORT BEACH, CA, July 9, 2024 - Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has divested itself of its subsidiary, Bazelet™ Health Systems Inc. in a shift in the Company’s direction away from the HealthTech sector following the acquisition of Advanced Executive Sales, LLC (AES). Following the acquisition of AES, the Company added an additional Director, Mr. Anthony Bianchi Esq., who will replace Ms. Frick who resigned in 2023 and will be serving as an Independent Director.  Mr. Bianchi is currently a practicing lawyer and will not be taking an active management position in the Company at this time; he will join Mr. Fred Luke and Mr. Greg Bauer, the Company’s new CEO, on the Company’s Board of Directors, while Mr. Michael Elzufon has resigned to join the Bazelet™ Board of Directors. In describing
Image
 SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra SSi Mantra integrates cutting edge advancements in robotic surgery, offering surgeons unparalleled precision and control for improved patient outcomes SS Innovations helps reinforce India's position as a global hub for technological innovation in healthcare Fort Lauderdale, FL., July 9, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC:  SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System (“SSi Mantra”) has been installed at Baidya & Banskota Hospital (“B&B Hospital”) in Kathmandu, Nepa l marking the first time a surgical robotic system has been ins
Image
  American Shared Hospital Services Announces Signing of Joint Venture Agreement for Gamma Knife Facility in Guadalajara, Mexico JV will Establish Company’s 4th International Center SAN FRANCISCO, CA, July 9, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has signed a joint venture agreement to partner in a Gamma Knife treatment facility in Guadalajara, Mexico. AMS has signed a Joint Venture (“JV”) agreement with Hospital San Javier (“HSJ”) to establish a Mexican JV (“Joint Venture”) to treat public and private cancer patients. AMS and HSJ will hold 70% and 30% ownership interests, respectively. The new Joint Venture will be upgrading HSJ’s existing Gamma Knife  ®  Perfexion™ system to an Esprit, Elekta’s newest Gamma Knife ®  radiosurgery system.  Gamma Knife  ®  radiosurgery i
Image
  REMSleep Holdings Inc. Receives 510(K) Clearance on Product CLEARWATER, FL, July 9, 2024 - REMSleep Holdings, Inc. (OTCQB: RMSL) announces the company has been awarded 510(K) Clearance for the new Deltawave CPAP Pillows Interface mask. The company would like to share the following correspondence with its shareholders: Re: K233415 Trade/Device Name: DELTAWAVE Nasal Pillows System Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: Class II Product Code: BZD Dated: October 4, 2023 Received: October 10, 2023 Dear Judy Strzepek: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassi
Image
  ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of patents in the U.S. and Canada NEW YORK, July 9, 2024 -- ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW”), a biopharmaceutical company specializing in the advancement of novel disease-modifying therapies for neurological and age-related disorders, announces plans to advance its recently patented Klotho gene therapy program for neurodegenerative disorders. ANEW has compelling initial data suggesting that maintaining elevated levels of Klotho in the body significantly contributes to longer, healthier lifespans. Conversely, the data reveals that individuals with depleted or lower-than-normal levels of Klotho are more susceptible to neurodegenerative disorders such as ALS, Alzheimer’s, and Parkinson’s Dise